Jeanne Loring, a co-founder of Aspen Neuroscience, is stepping down from her role as its chief scientific officer.
The La Jolla, CA-based company said Loring—professor emeritus at the Scripps Research Institute, where her work on the genomics of induced pluripotent stem cells laid the foundation for the company’s launch—will become a special advisor to the company’s research and development committee.
Earlier this year Aspen raised $70 million to advance its efforts to develop neuron replacement therapies that use a patient’s own living cells to treat Parkinson’s disease.
Sponsored · Video
A Fireside Chat with Medpace's Regulatory Affairs Director David Horton
Medpace
Sponsored · Whitepaper
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
Medpace
Xconomy Insight · Special Report
Insights, wisdom, and inspiration on what it takes
